Blood Cancer | defytime

top of page

Press Releases, News and Articles

Yescarta is the Second gene therapy approved by the FDA, targeting blood cancer

Oct 19, 2017
1 min

Yescarta is the Second gene therapy approved by the FDA, targeting blood cancer

U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma...

8 views

Featured Posts

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Recent Posts

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Rapidly Aging Cells May Contribute to Shorter Lifespan of Fabry Patients, Study Finds

Shorter Telomeres Increase Risk for MS Disability Progression

Archive

Search By Tags

bottom of page